These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7390646)

  • 1. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary.
    Jänne O; Kauppila A; Syrjälä P; Vihko R
    Int J Cancer; 1980 Feb; 25(2):175-9. PubMed ID: 7390646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and progesterone receptors in normal ovary and ovarian tumors.
    Lantta M
    Acta Obstet Gynecol Scand; 1984; 63(6):497-503. PubMed ID: 6507051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogen and progesterone receptors in human ovary and ovarian tumors].
    Han SW; Cao ZY; He B; Wang JH; Chen ML
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Sep; 20(3):253-6. PubMed ID: 2625328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
    Vierikko P; Kauppila A; Vihko R
    Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content.
    Iversen OE; Skaarland E; Utaaker E
    Gynecol Oncol; 1986 Jan; 23(1):65-76. PubMed ID: 3943754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate.
    Bergqvist A; Kullander S; Thorell J
    Acta Obstet Gynecol Scand Suppl; 1981; 101():75-81. PubMed ID: 6946676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors in human ovarian tumors.
    Willcocks D; Toppila M; Hudson CN; Tyler JP; Baird PJ; Eastman CJ
    Gynecol Oncol; 1983 Oct; 16(2):246-53. PubMed ID: 6313494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors in epithelial ovarian malignancies.
    Sutton GP; Senior MB; Strauss JF; Mikuta JJ
    Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
    Geyer H; Teufel G; de Gregorio G; Pfleiderer A
    Onkologie; 1984 May; 7 Suppl 2():44-52. PubMed ID: 6379538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptors in ovarian neoplasms.
    Ford LC; Berek JS; Lagasse LD; Hacker NF; Heins Y; Esmailian F; Leuchter RS; DeLange RJ
    Gynecol Oncol; 1983 Jun; 15(3):299-304. PubMed ID: 6862289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between steroid hormone receptors, histological and clinical parameters in ovarian carcinoma.
    Anderl P; Fuith LC; Daxenbichler G; Marth C; Dapunt O
    Gynecol Obstet Invest; 1988; 25(2):135-40. PubMed ID: 3371761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
    Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
    Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors.
    Friedlander ML; Quinn MA; Fortune D; Foo MS; Toppila M; Hudson CN; Russell P
    Gynecol Oncol; 1989 Feb; 32(2):184-90. PubMed ID: 2910780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
    Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
    Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
    Jones LA; Edwards CL; Freedman RS; Tan MT; Gallager HS
    Int J Cancer; 1983 Nov; 32(5):567-71. PubMed ID: 6315602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytosol receptor levels in malignant and benign ovarian tumors].
    Thurzó L; Falkay G; Sas M
    Orv Hetil; 1987 Aug; 128(36):1881-4, 1887. PubMed ID: 3658406
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogen and progesterone receptors in ovarian carcinoma].
    Kanajet D; Klarić P; Bolf-Benković L
    Jugosl Ginekol Perinatol; 1985; 25(1-2):13-6. PubMed ID: 3003465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
    Teufel G; Geyer H; de Gregorio G; Fuchs A; Kleine W; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):732-40. PubMed ID: 6559148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.